NFE2L2 and mood disorder: In cerebral areas, including the prefrontal cortex, Nrf2, a well-known redox-sensitive transcription factor involved in the cellular defense against oxidative stress, and BDNF, a growth factor which is involved in multiple aspects of synaptogenesis, have been hypothesized to represent therapeutic targets for mood disorders [41,42,43].